IP Library Granted Patent US 7,229,813
Granted Patent B2
US 7,229,813 · App. 11/021,825 · Granted Jun 12, 2007

Everninomicin biosynthetic proteins

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,229,813
App. No.
11/021,825
Granted
Jun 12, 2007
Kind
B2
Abstract

This invention is directed to nucleic acids which encode the proteins that direct the synthesis of the orthosomycin everninomicin and to use of the nucleic acids and proteins to produce compounds exhibiting antibiotic activity based on the everninomycin structure. The DNA sequence for the gene clusters responsible for encoding everninomicin biosynthetic genes, which provide the machinery for producing everninomicin, are provided. Thus, this invention provides the nucleic acid sequences needed to synthesize novel everninomicin-related compounds based on everninomicin, arising from modifications of the DNA sequence designed to change glycosyl and modified orsellinic acid groups contained in everninomicin. A Micromonospora site-specific integrase gene is also provided, which can be incorporated in a vector for integration into any actinomycete, and, particularly into Monospora . Thus, the invention further provides methods for introducing heterologous genes into an actinomycete chromosome using this particular vector.

Claims (6)

1. An isolated polypeptide comprising the amino acid sequence set forth in SEQ ID NO: 177.

2. The polypeptide of claim 1 fused to a heterologous polypeptide tag.

3. The polypeptide of claim 2 wherein the heterologous polypeptide tag is selected from the group consisting of a poly-histidine tag, a FLAG tag, a glutathione-S-transferase (GST) tag and a myc epitope tag.

4. A method for making the polypeptide of claim 1 comprising introducing a polynucleotide comprising the nucleotide sequence set forth in SEQ ID NO: 176 into a host cell and allowing expression of the polypeptide.

5. The method of claim 4 further comprising isolating the polypeptide from the host cell.

6. The isolated polypeptide of claim 1 consisting of the amino acid sequence set forth in SEQ ID NO: 177.

Assignments (1)
CHANGE OF NAME Recorded Aug 30, 2012
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028884/0151 →